e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females
Austin E. D., Cogan J. D., West J. D., Hedges L. K., Hamid R., Dawson E. P., Wheeler L. A., Parl F. F., Loyd J. E., Phillips J. A. III
Source:
Eur Respir J 2009; 34: 1093-1099
Journal Issue:
November
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Austin E. D., Cogan J. D., West J. D., Hedges L. K., Hamid R., Dawson E. P., Wheeler L. A., Parl F. F., Loyd J. E., Phillips J. A. III. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J 2009; 34: 1093-1099
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The definition of pulmonary hypertension: history, practical implications and current controversies
Asbestosis
Related content which might interest you:
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives
Source: Eur Respir J 2002; 20: 518-523
Year: 2002
Mutations in the bone morphogenic protein receptor 2 promoter in heritable pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
Source: Eur Respir J 2008; 31: 343-348
Year: 2008
Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension
Source: Eur Respir J, 50 (3) 1701370; 10.1183/13993003.01370-2017
Year: 2017
Genetics of pulmonary hypertension: from bench to bedside
Source: Eur Respir J 2002; 20: 741-749
Year: 2002
Inhibiting oestrogen signalling in pulmonary arterial hypertension: sex, drugs and research
Source: Eur Respir J, 50 (2) 1700983; 10.1183/13993003.00983-2017
Year: 2017
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease
Source: Eur Respir J 2004; 24: 371-374
Year: 2004
Estrogen receptor alpha gene polymorphisms and primary pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 352s
Year: 2005
Expression of fetal genes in pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation
Source: Eur Respir J 2003; 22: 560-562
Year: 2003
Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension
Source: Eur Respir J, 53 (6) 1801524; 10.1183/13993003.01524-2018
Year: 2019
Pathobiology of pulmonary arterial hypertension and right ventricular failure
Source: Eur Respir J 2012; 40: 1555-1565
Year: 2012
First identification of Krüppel-like factor 2 mutation in heritable pulmonary arterial hypertension
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Association of VDR, COL1A1 and CALCR genes polymorphisms with susceptibility to steroid osteoporosis in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension
Source: Eur Respir J 2009; 34: 1100-1110
Year: 2009
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects
Source: Eur Respir J, 50 (2) 1602337; 10.1183/13993003.02337-2016
Year: 2017
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 1668-1681
Year: 2016
BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation
Source: Eur Respir J 2007; 30: Suppl. 51, 250s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept